Literature DB >> 6854378

Beagle puppy model of intraventricular hemorrhage. Effect of indomethacin on cerebral blood flow.

L R Ment, W B Stewart, C C Duncan, D T Scott, R Lambrecht.   

Abstract

The newborn beagle puppy has been demonstrated to provide a good model for neonatal intraventricular hemorrhage (IVH). A study was designed to determine if indomethacin can prevent IVH and if indomethacin would produce changes in cerebral blood flow (CBF). Newborn beagle puppies were randomized by computer into two groups: one was pretreated with indomethacin, a known inhibitor of prostaglandin synthetase, and the other was saline. The dogs in both groups were then assigned either to undergo hemorrhagic hypotension/volume reexpansion insult or to receive no insult. Twenty percent of all pups receiving indomethacin and undergoing the insult experienced IVH, compared to 71% of the pups undergoing insult that had been pretreated with saline. Significant alterations in the blood pressure responses to the hemorrhagic hypotension/volume reexpansion insult were noted in the former group compared to the saline-pretreated pups subjected to insult. Finally, employing carbon-14 autoradiography for the determination of CBF, it was demonstrated that indomethacin decreases resting CBF of the newborn beagle pups and, in indomethacin-pretreated animals subjected to insult, prevents the increases in CBF seen in the saline-pretreated traumatized pups.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6854378     DOI: 10.3171/jns.1983.58.6.0857

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  10 in total

1.  Treating extremely low birthweight infants with prophylactic indomethacin. Evidence for short term benefits only.

Authors:  William McGuire; Peter W Fowlie
Journal:  BMJ       Date:  2002-01-12

Review 2.  Prophylactic indomethacin: systematic review and meta-analysis.

Authors:  P W Fowlie
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-03       Impact factor: 5.747

Review 3.  Neonatal brain hemorrhage (NBH) of prematurity: translational mechanisms of the vascular-neural network.

Authors:  Tim Lekic; Damon Klebe; Roy Poblete; Paul R Krafft; William B Rolland; Jiping Tang; John H Zhang
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

Review 4.  Dogs as a Natural Animal Model of Epilepsy.

Authors:  Wolfgang Löscher
Journal:  Front Vet Sci       Date:  2022-06-22

5.  Effects of antioxidants on the blood-brain barrier and postischemic hyperemia.

Authors:  E Tasdemiroglu; P D Christenberry; J L Ardell; R B Chronister; A E Taylor
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

6.  Effect of infusion rate of indomethacin on cerebrovascular responses in preterm neonates.

Authors:  P Colditz; D Murphy; P Rolfe; A R Wilkinson
Journal:  Arch Dis Child       Date:  1989-01       Impact factor: 3.791

7.  Effects of prolonged versus acute indomethacin therapy in very low birth-weight infants with patent ductus arteriosus.

Authors:  P G Rhodes; M G Ferguson; N S Reddy; J A Joransen; J Gibson
Journal:  Eur J Pediatr       Date:  1988-06       Impact factor: 3.183

Review 8.  The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate.

Authors:  Heather J McCrea; Laura R Ment
Journal:  Clin Perinatol       Date:  2008-12       Impact factor: 3.430

9.  Intraventricular Hemorrhage: Risk Factors and Association With Patent Ductus Arteriosus Treatment in Extremely Preterm Neonates.

Authors:  Ijab Khanafer-Larocque; Amuchou Soraisham; Amelie Stritzke; Essa Al Awad; Sumesh Thomas; Prashanth Murthy; Majeeda Kamaluddeen; James N Scott; Khorshid Mohammad
Journal:  Front Pediatr       Date:  2019-10-22       Impact factor: 3.418

10.  Neuroprotective effect of indomethacin in normal perfusion pressure breakthrough phenomenon.

Authors:  Manuel Revuelta; Alvaro Zamarrón; Jose Fortes; Gregorio Rodríguez-Boto; Raquel Gutiérrez-González
Journal:  Sci Rep       Date:  2020-09-22       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.